Serum n-glycomic biomarkers predict treatment escalation in in�ammatory bowel disease

HIGHLIGHTS

  • who: Posted Date August et al. from the Ludger Ltd, Culham Science Centre, Abingdon, Oxfordshire, United Kingdom Translational Gastroenterology Unit, University of Oxford, Oxford, United Kingdom have published the Article: Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inufffdammatory Bowel Disease, in the Journal: (JOURNAL)
  • what: The authors show that the future need for surgical intervention or escalation of medical treatment to biologic drugs can be predicted in IBD patients at diagnosis and have validated this finding in an independent cohort of 54 IBD patients using glycomics biomarkers which is the novelty of this study . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?